Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001999
Filing Date
2025-03-03
Accepted
2025-03-03 07:18:33
Documents
115
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avbp-20241231x10k.htm   iXBRL 10-K 2310572
2 EX-19 avbp-20241231xex19.htm EX-19 174839
3 EX-23.1 avbp-20241231xex23d1.htm EX-23.1 4377
4 EX-31.1 avbp-20241231xex31d1.htm EX-31.1 8699
5 EX-31.2 avbp-20241231xex31d2.htm EX-31.2 9678
6 EX-32 avbp-20241231xex32.htm EX-32 6174
7 GRAPHIC avbp-20241231x10k001.jpg GRAPHIC 80406
8 GRAPHIC avbp-20241231x10k003.jpg GRAPHIC 44610
9 GRAPHIC avbp-20241231x10k005.jpg GRAPHIC 36870
10 GRAPHIC avbp-20241231x10k006.jpg GRAPHIC 22762
11 GRAPHIC avbp-20241231x10k007.jpg GRAPHIC 68080
12 GRAPHIC avbp-20241231x10k009.jpg GRAPHIC 84012
13 GRAPHIC avbp-20241231x10k010.jpg GRAPHIC 26856
14 GRAPHIC avbp-20241231x10k011.jpg GRAPHIC 71272
15 GRAPHIC avbp-20241231x10k012.jpg GRAPHIC 94129
16 GRAPHIC avbp-20241231x10k013.jpg GRAPHIC 32546
17 GRAPHIC avbp-20241231x10k014.jpg GRAPHIC 17852
18 GRAPHIC avbp-20241231x10k015.jpg GRAPHIC 15877
19 GRAPHIC avbp-20241231x10k016.jpg GRAPHIC 16724
20 GRAPHIC avbp-20241231x10k017.jpg GRAPHIC 17338
21 GRAPHIC avbp-20241231x10k018.jpg GRAPHIC 18400
22 GRAPHIC avbp-20241231x10k019.jpg GRAPHIC 17674
23 GRAPHIC avbp-20241231x10k020.jpg GRAPHIC 86845
24 GRAPHIC avbp-20241231x10k021.jpg GRAPHIC 97455
25 GRAPHIC avbp-20241231x10k022.jpg GRAPHIC 80804
26 GRAPHIC avbp-20241231x10k023.jpg GRAPHIC 82560
27 GRAPHIC avbp-20241231x10k024.jpg GRAPHIC 110374
28 GRAPHIC avbp-20241231x10k025.jpg GRAPHIC 94398
29 GRAPHIC avbp-20241231x10k026.jpg GRAPHIC 60902
30 GRAPHIC avbp-20241231x10k028.jpg GRAPHIC 101746
31 GRAPHIC avbp-20241231x10k029.jpg GRAPHIC 65603
32 GRAPHIC avbp-20241231x10k030.jpg GRAPHIC 73143
33 GRAPHIC avbp-20241231x10k031.jpg GRAPHIC 62895
34 GRAPHIC avbp-20241231x10k032.jpg GRAPHIC 77001
35 GRAPHIC avbp-20241231x10k033.jpg GRAPHIC 60535
36 GRAPHIC avbp-20241231x10k034.jpg GRAPHIC 60983
37 GRAPHIC avbp-20241231x10k036.jpg GRAPHIC 59754
38 GRAPHIC avbp-20241231x10k037.jpg GRAPHIC 41043
39 GRAPHIC avbp-20241231x10k038.jpg GRAPHIC 89951
40 GRAPHIC avbp-20241231xex19003.jpg GRAPHIC 2790
41 GRAPHIC avbp-20241231xex19004.jpg GRAPHIC 2938
  Complete submission text file 0001558370-25-001999.txt   13029776

Data Files

Seq Description Document Type Size
42 EX-101.SCH avbp-20241231.xsd EX-101.SCH 50894
43 EX-101.CAL avbp-20241231_cal.xml EX-101.CAL 49415
44 EX-101.DEF avbp-20241231_def.xml EX-101.DEF 156007
45 EX-101.LAB avbp-20241231_lab.xml EX-101.LAB 462447
46 EX-101.PRE avbp-20241231_pre.xml EX-101.PRE 331631
118 EXTRACTED XBRL INSTANCE DOCUMENT avbp-20241231x10k_htm.xml XML 1064008
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41929 | Film No.: 25693768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)